BMS-184476 Bristol-Myers Squibb.
作者信息
Ojima Iwao, Geney Raphaël
机构信息
Department of Chemistry, Institute of Chemical Biology and Drug Discovery, State University of New York at Stony Brook, Stony Brook, NY 11794-3400, USA.
出版信息
Curr Opin Investig Drugs. 2003 Jun;4(6):732-6.
PMID:12901233
Abstract
BMS-184476 is a taxane analog under development by Bristol-Myers Squibb for the potential treatment of solid tumors. By February 2001, it had entered phase II trials and, as of May 2002, phase II studies had been carried out in patients with a number of tumor types, including breast, ovarian and non-small-cell lung cancer.
摘要
Zotero 插件